K2 Capital Acquisition Corp (KTWO) Stock Price & Analysis
K2 Capital Acquisition Corp (KTWO) rose 0.00% to USD 10.03 as of July 26, 2026 at 16:45 UTC, according to Nexqual real-time market data.
KTWO last closed at USD 10.03; the session ranged USD 10.03–10.03 on volume of 4 shares. Market capitalization is $201.01M, with a 52-week range of USD 9.84–10.07 (NGM). Source: Nexqual, July 26, 2026 at 16:45 UTC.
Key Statistics (as of July 26, 2026 at 16:45 UTC)
| Price | USD 10.03 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.03 |
| Open | USD 9.97 |
| Day Range | USD 10.03 – 10.03 |
| 52-Week Range | USD 9.84 – 10.07 |
| Volume | 4 shares |
| Market Cap | $201.01M |
| Exchange | NGM |
Technical Analysis (KTWO)
Nexqual's technical model rates KTWO "BUY" based on 5 bullish and 1 bearish signals across 103 daily candles, as of July 26, 2026 at 16:45 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 60.65 (neutral) |
| vs SMA50 | Above (USD 9.96) |
| MACD | 0.02 (positive) |
Analyst Ratings (KTWO)
Wall Street analysts rate KTWO "None", per Nexqual as of July 26, 2026 at 16:45 UTC.
| Consensus Rating | None |
|---|
Earnings (KTWO)
Source: Nexqual, July 26, 2026 at 16:45 UTC.
Financials & Fundamentals (KTWO)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| Current Ratio | 0.75 |
| Total Cash | $990,067 |
| Total Debt | $0 |
Source: Nexqual, July 26, 2026 at 16:45 UTC.
Financial Health Score (KTWO)
Nexqual rates K2 Capital Acquisition Corp's overall financial health "Weak" across five dimensions, as of July 26, 2026 at 16:45 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — $990K cash, no debt |
| Cash Flow | Weak — Operating cash flow $0 |
| Efficiency | Mixed — No data |
Ownership (KTWO)
| Insider Ownership | +2.31% |
|---|---|
| Institutional Ownership | +84.01% |
| Shares Outstanding | 14.13M |
| Float | 12.56M |
| Short % of Float | +0.03% |
Source: Nexqual, July 26, 2026 at 16:45 UTC.
Leadership (KTWO)
K2 Capital Acquisition Corp is led by Karan Thakur (age 33), CEO & Chairman, per Nexqual as of July 26, 2026 at 16:45 UTC.
| CEO & Chairman | Karan Thakur (age 33) |
|---|---|
| Chief Financial Officer | Glenn Charles Worman (age 66) |
| Vice President | Alexander W. Tjiang (age 27) |
Major Backers & Investors (KTWO)
Notable institutional backers of K2 Capital Acquisition Corp include Highbridge Capital Management, LLC., Aristeia Capital, LLC, Linden Advisors LP, according to Nexqual as of July 26, 2026 at 16:45 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Highbridge Capital Management, LLC. | 8.76% |
| Aristeia Capital, LLC | 7.08% |
| Linden Advisors LP | 5.31% |
| Shaolin Capital Management LLC | 4.98% |
| AQR Arbitrage LLC | 4.76% |
| Magnetar Financial LLC | 4.6% |
| Berkley W R Corp | 4.23% |
| Mangrove Partners IM, LLC | 4.18% |
Source: Nexqual, July 26, 2026 at 16:45 UTC.
From K2 Capital Acquisition Corp's Latest SEC 10-K Filing (filed 2026-03-26)
Key Strengths & Strategy (as disclosed to the SEC)
- Because we are able to complete our initial business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business to fit its needs and desires.
Partnerships
- The European technology industry represents a large target market, with approximately $44 billion of capital invested in technology startups in 2025 and over 40,000 funded technology companies, according to the State of European Tech 2025 report by Atomico, Orrick, HSBC, AWS and Slush.
- Our initial shareholders, officers and directors will enter into a letter agreement with us, pursuant to which they will agree to waive their redemption rights with respect to any founder shares and any public shares held by them in connection with the completion of our initial business combination.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OFIX | Orthofix Medical Inc. | USD 11.25 | ▲ 2.09% |
| ATRC | AtriCure, Inc. | USD 35.04 | ▲ 4.53% |
| JRVR | James River Group Holdings, Inc | USD 4.71 | ▲ 3.97% |
| CNMD | CONMED Corporation | USD 42.68 | ▲ 1.62% |
| PAHC | Phibro Animal Health Corporatio | USD 34.04 | ▲ 0.67% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 16:45 UTC. This page is informational and not investment advice.